Syndax Pharmaceuticals SNDX
NASDAQ SNDX
$9.44 -0.05 (-0.58%)
As of: Nov 11, 2026 · 9:47 AM EST

Syndax Pharmaceuticals (SNDX) Total Non-Current Liabilities (2015 - 2026)

Updated

Syndax Pharmaceuticals (SNDX) recorded Total Non-Current Liabilities of $588.89 million in Q3 2026, up 82.8% from $322.18 million a year earlier and unchanged from the prior quarter.

Analysis

Syndax Pharmaceuticals (SNDX) Total Non-Current Liabilities (2015 - 2026) Analysis & Trends

At the end of FY2025, Syndax Pharmaceuticals reported Total Non-Current Liabilities of $344.96 million, up 3.5% from FY2024.

  • Annual Total Non-Current Liabilities has a five-year compound annual growth rate of 63.5% (FY2020 to FY2025).
  • Across earlier years, Total Non-Current Liabilities came in at $333.14 million in FY2024, $588,000 in FY2023 (-18.6%), $722,000 in FY2022 (-96.5%) and $20.61 million in FY2021 (-30.3%).
  • The Q3 2026 figure is the highest quarterly Total Non-Current Liabilities in data going back to Q4 2015.
  • On a year-over-year basis, Total Non-Current Liabilities has increased for four consecutive quarters, with growth averaging 42.8% over the last four quarters.
  • Peak year-over-year performance for Total Non-Current Liabilities in the last five years was growth of 82.8% in Q3 2026, against a decline of 99.8% in Q3 2024 at the low end.
  • Per Business Quant, the preceding three quarters came in at $588.88 million (Q2 2026), $344.87 million (Q1 2026) and $344.96 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 60.81 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 102.65 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 117.60 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 79.95 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -36.84 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 76.12 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 36.05 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 96.04 Bn
10 Syndax Pharmaceuticals 854.00 Mn -867.10 Mn 69.30 Mn 588.89 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 588.89 Mn
Jun 30, 2026 588.88 Mn
Mar 31, 2026 344.87 Mn
Dec 31, 2025 344.96 Mn
Sep 30, 2025 322.18 Mn
Jun 30, 2025 325.74 Mn
Mar 31, 2025 331.10 Mn
Dec 31, 2024 333.14 Mn
Sep 30, 2024 2,000.00
Jun 30, 2024 137,000.00
Mar 31, 2024 334,000.00
Dec 31, 2023 588,000.00
Sep 30, 2023 864,000.00
Jun 30, 2023 1.13 Mn
Mar 31, 2023 600,000.00
Dec 31, 2022 722,000.00
Sep 30, 2022 782,000.00
Jun 30, 2022 13.57 Mn
Mar 31, 2022 17.12 Mn
Dec 31, 2021 20.61 Mn
API Access

Syndax Pharmaceuticals Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=SNDX&period=max&api_key=YOUR_API_KEY